Orchard Therapeutics

Orchard Therapeutics

Orchard Therapeutics

Orchard Therapeutics is a biotechnology company
Type
B2b
Founded
2015
Raised
$510.9M
Follow us
Alexa global traffic share
Latest funding Show all
$200,000,000
IPO - 2018
$150,000,000
Venture capital (Series C) - 2018
RA Capital Management Baillie Gifford Perceptive Advisors +13
Team Size
2
Employees
FinSMEs

Orchard Therapeutics Prices Initial Public Offering

Stock markets Health Costs
$200,000,000 IPO
PE HUB , FinSMEs

VC-backed Orchard Therapeutics goes public

Stock markets
$150,000,000 Venture capital (Series C)
FinSMEs , Xconomy

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health
$110,000,000 Venture capital (Series B)
PE HUB

| Gene therapy developer Orchard Therapeutics raises $110 million: Reuters

Health Funding
$20,000,000 Grant
FierceBiotech

Orchard gets $20M to trial ‘bubble boy’ gene therapy

£21,000,000 Venture capital (Series A)
b3cnewswire

Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies